Old Web
English
Sign In
Acemap
>
Paper
>
A Prospective Phase II of Daratumumab in Previously Treated Systemic Light-Chain (AL) Amyloidosis: Updated Results
A Prospective Phase II of Daratumumab in Previously Treated Systemic Light-Chain (AL) Amyloidosis: Updated Results
2019
Murielle Roussel
Bertrand Arnulf
Anne-Marie Stoppa
Lionel Karlin
Aurore Perrot
Margaret Macro
Antoine Huart
Laurent Frenzel
Pierre Morel
Salomon Manier
Véronique Dorvaux
Giampaolo Merlini
Giovanni Palladini
David Lavergne
Bruno Royer
Frank Bridoux
Arnaud Jaccard
Keywords:
Daratumumab
Pathology
AL amyloidosis
Medicine
Immunoglobulin light chain
previously treated
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]